Learn more

CLINICAL GENOMICS PTY LTD

Overview
  • Total Patents
    151
  • GoodIP Patent Rank
    23,974
  • Filing trend
    ⇧ 300.0%
About

CLINICAL GENOMICS PTY LTD has a total of 151 patent applications. It increased the IP activity by 300.0%. Its first patent ever was published in 2002. It filed its patents most often in EPO (European Patent Office), Australia and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets biotechnology, measurement and chemical engineering are VELA OPERATIONS SINGAPORE PTE LTD, LIVING MICROSYSTEMS INC and ALTRATECH LTD.

Patent filings per year

Chart showing CLINICAL GENOMICS PTY LTDs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Dunne Robert 37
#2 Molloy Peter Laurence 32
#3 Young Graeme P 29
#4 Pedersen Susanne 28
#5 Lapointe Lawrence Charles 27
#6 Wilson William J 24
#7 Lockett Trevor John 23
#8 Lapointe Lawrence C 21
#9 Baker Rohan 20
#10 Molloy Peter 19

Latest patents

Publication Filing date Title
AU2018333844A1 Method for methylation analysis
AU2015258259A1 Epigenetic markers of colorectal cancers and diagnostic methods using the same
US2017246626A1 Test device and method
AU2015203005A1 A method of diagnosing neoplasms
SG11201610113YA Method for methylation analysis
AU2015202210A1 A method of diagnosing neoplasms - II
JP2014158468A Detection method
EP2922973A1 A method of detecting methylation
AU2013262435A1 A method of screening for colorectal cancer
US2015141275A1 Diagnostic gene marker panel for colorectal cancer
AU2012300196A1 DNA methylation in colorectal and breast cancer diagnostic methods
WO2013003898A1 Method for detection of cancer in a patient
KR20140064732A A method of diagnosing neoplasms
WO2012113028A1 Isolation of a target bioentity from a biological sample
AU2011320021A1 Method of microvesicle enrichment
WO2012054975A1 Method of microvesicle enrichment
CN103314114A Epigenetic markers of colorectal cancers and diagnostic methods using the same
AU2011202684A1 Nucleic acid markers for use in determining predisposition to neoplasm and/or adenoma
WO2010135786A1 A method for diagnosing neoplasms and molecules for use therein
CN102458665A Method and apparatus for isolating a target bioentity from a biological sample